ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,721,365 | -7.5% | 1,311,009 | +3.4% | 0.00% | 0.0% |
| Q2 2023 | $39,696,578 | -34.1% | 1,268,261 | -40.6% | 0.00% | 0.0% |
| Q1 2023 | $60,194,288 | +244.5% | 2,135,306 | +219.4% | 0.00% | +50.0% |
| Q4 2022 | $17,471,518 | -22.1% | 668,638 | -33.4% | 0.00% | 0.0% |
| Q3 2022 | $22,418,000 | -29.8% | 1,003,921 | -6.4% | 0.00% | -33.3% |
| Q2 2022 | $31,957,000 | +393.6% | 1,072,723 | +335.9% | 0.00% | +200.0% |
| Q1 2022 | $6,474,000 | +1029.8% | 246,075 | +898.7% | 0.00% | – |
| Q4 2021 | $573,000 | – | 24,640 | +615900.0% | 0.00% | – |
| Q3 2021 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 4 | +100.0% | 0.00% | – |
| Q4 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q1 2020 | $10,533,000 | -81.6% | 730,421 | -73.9% | 0.00% | -83.3% |
| Q4 2019 | $57,195,000 | -41.5% | 2,803,700 | -44.0% | 0.01% | -50.0% |
| Q3 2019 | $97,717,000 | -41.6% | 5,008,516 | -32.6% | 0.01% | -40.0% |
| Q2 2019 | $167,405,000 | -60.6% | 7,427,025 | -36.2% | 0.02% | -60.8% |
| Q1 2019 | $425,079,000 | -9.8% | 11,649,172 | -27.1% | 0.05% | -21.5% |
| Q4 2018 | $471,364,000 | -51.2% | 15,973,051 | -29.8% | 0.06% | -40.4% |
| Q3 2018 | $965,611,000 | +0.9% | 22,752,378 | -2.2% | 0.11% | -0.9% |
| Q2 2018 | $957,200,000 | -29.5% | 23,255,590 | -0.7% | 0.11% | -31.7% |
| Q1 2018 | $1,357,517,000 | +10.8% | 23,421,617 | +4.6% | 0.16% | +11.8% |
| Q4 2017 | $1,225,283,000 | +4.6% | 22,387,768 | -2.9% | 0.14% | +1.4% |
| Q3 2017 | $1,171,787,000 | -12.0% | 23,048,525 | +0.3% | 0.14% | -14.5% |
| Q2 2017 | $1,332,068,000 | -0.5% | 22,978,575 | +0.4% | 0.17% | -2.4% |
| Q1 2017 | $1,338,604,000 | +5.7% | 22,882,118 | +0.4% | 0.17% | +0.6% |
| Q4 2016 | $1,266,978,000 | +18.5% | 22,795,572 | +0.3% | 0.17% | +19.0% |
| Q3 2016 | $1,069,157,000 | +9.1% | 22,733,505 | +0.3% | 0.14% | +6.0% |
| Q2 2016 | $980,005,000 | +26.8% | 22,674,809 | +0.3% | 0.13% | +25.2% |
| Q1 2016 | $773,078,000 | -56.7% | 22,611,242 | +0.5% | 0.11% | -55.4% |
| Q4 2015 | $1,786,741,000 | +35.9% | 22,508,708 | +0.4% | 0.24% | +28.3% |
| Q3 2015 | $1,314,782,000 | -8.3% | 22,409,782 | +0.5% | 0.19% | +1.6% |
| Q2 2015 | $1,434,435,000 | +5.9% | 22,294,604 | +0.4% | 0.18% | +7.0% |
| Q1 2015 | $1,354,197,000 | +5.4% | 22,210,876 | +1.3% | 0.17% | +3.0% |
| Q4 2014 | $1,284,497,000 | +37.0% | 21,934,725 | +0.3% | 0.17% | +31.5% |
| Q3 2014 | $937,746,000 | -7.9% | 21,874,183 | +8.1% | 0.13% | -7.3% |
| Q2 2014 | $1,018,633,000 | +13.4% | 20,239,089 | -0.6% | 0.14% | +9.6% |
| Q1 2014 | $898,022,000 | +7.7% | 20,367,925 | -0.7% | 0.12% | +5.9% |
| Q4 2013 | $833,909,000 | +21.9% | 20,509,325 | +0.8% | 0.12% | +12.4% |
| Q3 2013 | $684,295,000 | +17.6% | 20,353,825 | +0.4% | 0.10% | +10.5% |
| Q2 2013 | $581,647,000 | – | 20,280,594 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |